Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D'Erasmo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2014
Bone damage in type 2 diabetes mellitusV Carnevale, E Romagnoli, L D'Erasmo, et al.
Endocrine|August 18, 2012
Genetic determinants and early carotid atherosclerosis: is there a role for the ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP-1) K121Q polymorphism? Preliminary results in non diabetic individualsP Coletta, G Barbarossa, D Pergolini, et al.
Diabetes Research and Clinical Practice|January 29, 2014
The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward?G Barbarossa, A Renzi, L D'Erasmo, et al.
European Journal of Internal Medicine|June 21, 2014
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variantsM Del Ben, L Polimeni, M Brancorsini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2012
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individualsM Maranghi, S Prudente, L D'Erasmo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 25, 2014
Bone damage in type 2 diabetes mellitusV Carnevale, E Romagnoli, L D'Erasmo, et al.
Endocrine|August 18, 2012
Genetic determinants and early carotid atherosclerosis: is there a role for the ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP-1) K121Q polymorphism? Preliminary results in non diabetic individualsP Coletta, G Barbarossa, D Pergolini, et al.
Diabetes Research and Clinical Practice|January 29, 2014
The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward?G Barbarossa, A Renzi, L D'Erasmo, et al.
European Journal of Internal Medicine|June 21, 2014
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variantsM Del Ben, L Polimeni, M Brancorsini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2012
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individualsM Maranghi, S Prudente, L D'Erasmo, et al.
Pageof 1